| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Zevra Therapeutics, Inc. (ZVRA) has 11 insiders with recent SEC Form 4 filings, including 17 buys and 0 sells. ZVRA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 222.0K | $2.47M | - | |
| CFO | 192.0K | $2.14M | - | |
| Dir | 84.2K | $936.3K | - | |
| Other | 48.1K | $535.1K | -1,794 | |
| Dir | 45.0K | $500.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 9, 2023 | Pascoe Richard W57 | Chief Executive Officer | Buy | 10,000 | $4.20 | $41,978.00 | +50.1% | +27.3% | +43.5% | |
| Mar 9, 2023 | Plooster Matthew R | Director | Buy | 11,000 | $4.20 | $46,148.30 | +146.7% | +27.3% | +43.5% | |
| Mar 9, 2023 | Tierney David S53 | Director | Buy | 5,000 | $4.15 | $20,731.50 | +85.7% | +27.3% | +43.5% | |
| Jan 13, 2023 | Clifton R. Laduane55 | CFO, Secretary &Treasurer | Buy | 635 | $5.81 | $3,689.83 | +3.5% | +13.9% | +7.2% | |
| Jan 13, 2023 | Pascoe Richard W57 | Chief Executive Officer | Buy | 9,500 | $5.44 | $51,679.05 | +90.7% | +13.9% | +7.2% | |
| Sep 30, 2022 | Clifton R. Laduane55 | CFO, Secretary &Treasurer | Buy | 1,000 | $5.98 | $5,981.20 | +6.7% | -26.9% | -22.8% | |
| May 25, 2022 | Mickle Travis C | President &CEO | Buy | 13,000 | $4.38 | $56,996.00 | +17.1% | +26.0% | +12.9% | |
| May 25, 2022 | Tierney David S53 | Director | Buy | 2,000 | $4.39 | $8,780.00 | +52.2% | +26.0% | +12.9% | |
| May 20, 2022 | Seymour Tamara A67 | Director | Buy | 200 | $4.87 | $974.00 | New | +12.9% | +8.4% | |
| May 18, 2022 | Plooster Matthew R | Director | Buy | 5,000 | $4.96 | $24,780.34 | +29.5% | +16.0% | +6.1% |